Baylor College of Medicine: Quality Control for Single Cell Imaging
April 13, 2022
April 13, 2022
HOUSTON, Texas, April 13 (TNSJou) -- The Baylor College of Medicine issued the following news:
One size doesn't necessarily fit all when it comes to testing the effects, including cancer and other diseases, of endocrine disrupting chemicals (EDC) or toxins, which target many factors, including the estrogen receptor (ER). Most current screening uses high throughput assays that only focus on bulk population analysis and/or engineered systems without taking into account phenotypic . . .
One size doesn't necessarily fit all when it comes to testing the effects, including cancer and other diseases, of endocrine disrupting chemicals (EDC) or toxins, which target many factors, including the estrogen receptor (ER). Most current screening uses high throughput assays that only focus on bulk population analysis and/or engineered systems without taking into account phenotypic . . .